Regenerative signaling pathways

Regenerative signaling pathways represent a collection of evolutionary conserved molecular cascades, most notably Wnt, Notch, Hedgehog, Hippo, and TGF-beta, that orchestrate tissue morphogenesis, homeostasis, and repair (Takebe et al., 2015, Nature Medicine). These pathways function as critical regulators of adult stem cell niche maintenance and progenitor cell differentiation, making them focal points for regenerative medicine and oncology (Clevers, 2006, Nature). In the context of injury or degenerative conditions like heart failure or neurodegeneration, therapeutic modulation aims to re-activate these pathways to stimulate endogenous repair mechanisms (Yu et al., 2015, Nature Reviews Molecular Cell Biology). Conversely, the aberrant constitutive activation of these pathways is a primary driver of tumorigenesis and the maintenance of cancer stem cells, leading to the development of various pathway inhibitors currently in clinical trials (Nusse & Clevers, 2017, Cell). The primary pharmacological challenge lies in achieving precise spatio-temporal control, as systemic modulation often results in significant off-target toxicities or an increased risk of malignant transformation (Wang et al., 2014, Cell Stem Cell).

Other names

Tissue regeneration pathwaysDevelopmental signaling pathwaysRepair signaling networksStem cell signaling pathways

Therapeutic agents modulate these pathways by targeting key nodes—such as GPCR-like receptors (Frizzled, Smoothened), intracellular kinases (GSK3, LATS1/2), or transcriptional co-activators (beta-catenin, YAP/TAZ)—to either restore homeostatic signaling in degenerative states or suppress pathological signaling in malignancy (Takebe et al., 2015, Nature Medicine; Nusse & Clevers, 2017, Cell).